EFACTS’ (European Friedreich’s Ataxia Consortium for Translational Studies) Annual Newsletter 2013.
This third issue of EFACTS NEWS presents an update on the status of the EFACTS patient registry as baseline assessments are completed for a core sample of patients. Progress in the various research areas has been made over the past year. Patients are particularly interested in treatment options and may be glad to read that this newsletter contains information on progress in a clinical trial with a potential therapeutic candidate. There have been a number of publications on findings derived from EFACTS projects, which are also presented in this newsletter.
Saturday, October 5, 2013
Friday, October 4, 2013
Cognitive Deficits In Friedreich Ataxia Correlate with Micro-structural Changes in Dentatorubral Tract
Cognitive Deficits In Friedreich Ataxia Correlate with Micro-structural Changes in Dentatorubral Tract. Akhlaghi H, Yu J, Corben L, Georgiou-Karistianis N, Bradshaw JL, Storey E, Delatycki MB, Egan GF; Cerebellum (London, England) : 2013 Oct 2 pg. DOI 10.1007/s12311-013-0525-4
Keywords: Friedreich's ataxia, Dentato-rubral tract, Dentato-thalamic tract, Dentate nucleus, Diffusion MRI
Keywords: Friedreich's ataxia, Dentato-rubral tract, Dentato-thalamic tract, Dentate nucleus, Diffusion MRI
Monday, September 30, 2013
Friedreich's Ataxia, Frataxin, PIP5K1B: Echo of a Distant Fracas
Friedreich's Ataxia, Frataxin, PIP5K1B: Echo of a Distant Fracas. Aurélien Bayot and Pierre Rustin, Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 725635, 7 pages, 2013. doi:10.1155/2013/725635
FULL TEXT PDF
FULL TEXT PDF
Friedreich's Ataxia Active Research Grants funded by MDA (Years 2013,2014,2015,2016)
Friedreich's Ataxia Active Research Grants funded by MDA (Years 2013,2014,2015,2016)
Marek Napierala Ph.D., Correction of the Friedreich’s ataxia gene defect using zinc finger nucleases (2014-2016).
Giovanni Coppola MD, Peripheral Biomarkers in Friedreich's Ataxia (2013-2014).
Ronald Mark Payne M.D., Mechanism of Heart Failure in Friedreich Ataxia (2013-2015).
Jeffrey D. Milbrandt MD, PhD, Manipulating Schwann cell metabolism to treat peripheral neuropathy (2012-2015).
David Lynch MD, PhD, Insulin resistance in Friedreich ataxia (2012-2013)
Joseph Sarsero Ph.D., Development of an improved GAA repeat expansion mouse model of Friedreich ataxia (2012-2014)
Des Richardson Ph.D., D.Sc., Development of Iron Complexes for the Treatment of Friedreich’s Ataxia (2012-2014)
Source: MDA Active Research Grants, CALENDAR YEAR(s): 2013,2014,2015,2016
Marek Napierala Ph.D., Correction of the Friedreich’s ataxia gene defect using zinc finger nucleases (2014-2016).
Giovanni Coppola MD, Peripheral Biomarkers in Friedreich's Ataxia (2013-2014).
Ronald Mark Payne M.D., Mechanism of Heart Failure in Friedreich Ataxia (2013-2015).
Jeffrey D. Milbrandt MD, PhD, Manipulating Schwann cell metabolism to treat peripheral neuropathy (2012-2015).
David Lynch MD, PhD, Insulin resistance in Friedreich ataxia (2012-2013)
Joseph Sarsero Ph.D., Development of an improved GAA repeat expansion mouse model of Friedreich ataxia (2012-2014)
Des Richardson Ph.D., D.Sc., Development of Iron Complexes for the Treatment of Friedreich’s Ataxia (2012-2014)
Source: MDA Active Research Grants, CALENDAR YEAR(s): 2013,2014,2015,2016
Sunday, September 29, 2013
Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia)
Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia) Mohammad Hossein Salehi, Behnam Kamalidehghan, Massoud Houshmand, Omid Aryani, Majid Sadeghizadeh, Mir Majid Mossalaeie. Molecular Biology Reports, September 2013, DOI 10.1007/s11033-013-2767-0
OPEN ACCESS, FULL TEXT
OPEN ACCESS, FULL TEXT
Friday, September 27, 2013
Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy
Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy. Miguel A. Varela, Thomas C. Roberts, Matthew J. A. Wood;
Neurotherapeutics, September 2013
Keywords: non-coding RNAs (ncRNAs), epigenetic mechanisms, gene expression, microRNAs (miRNAs), MECP2, EZH2, cancer, neurological diseases.
Neurotherapeutics, September 2013
Keywords: non-coding RNAs (ncRNAs), epigenetic mechanisms, gene expression, microRNAs (miRNAs), MECP2, EZH2, cancer, neurological diseases.
Management of the Rigid Cavus Foot in Children and Adolescents
Management of the Rigid Cavus Foot in Children and Adolescents . Dennis S. Weiner, Kerwyn Jones, David Jonah, Martin S. Dicintio; Foot and Ankle Clinics, Available online 26 September 2013. http://dx.doi.org/10.1016/j.fcl.2013.08.007
Keywords: Rigidity; Cavus; Salvage; Midtarsal; Osteotomy
Keywords: Rigidity; Cavus; Salvage; Midtarsal; Osteotomy
Tuesday, September 24, 2013
Abnormal Base Excision Repair at Trinucleotide Repeats Associated with Diseases: A Tissue-Selective Mechanism
Abnormal Base Excision Repair at Trinucleotide Repeats Associated with Diseases: A Tissue-Selective Mechanism. Goula, Agathi-Vasiliki; Merienne, Karine. Genes 2013, 4, 375-387.
OPEN ACCESS, FULL TEXT PDF
OPEN ACCESS, FULL TEXT PDF
Saturday, September 21, 2013
Mitochondrial DNA variations and evidence of haplogroups in Indian Friedreich's ataxia (FRDA) patients
Mitochondrial DNA variations and evidence of haplogroups in Indian Friedreich's ataxia (FRDA) patients. I. Mudila, F. Mohammed, A. Srivastava; Journal of the Neurological Sciences, Volume 333, Supplement 1, 15 October 2013, Pages e708-e709. http://dx.doi.org/10.1016/j.jns.2013.07.2446
Variations at positions 16 519, 4883 and 5178 suggest that these variations may act as modifier for the disease.
Variations at positions 16 519, 4883 and 5178 suggest that these variations may act as modifier for the disease.
Voxel-based morphometry in Friedreich's ataxia: A prospective study
Voxel-based morphometry in Friedreich's ataxia: A prospective study. C. Bonilha da Silva, C.L. Yasuda, A. D'Abreu, I. Lopes-Cendes, F. Cendes, M.C. França Jr.; Journal of the Neurological Sciences, Volume 333, Supplement 1, 15 October 2013, Pages e659-e660. http://dx.doi.org/10.1016/j.jns.2013.07.2285
VBM analyses showed that FRDA patients have progressive GM and WM loss in two years
VBM analyses showed that FRDA patients have progressive GM and WM loss in two years
Subscribe to:
Posts (Atom)
